Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta …

L Martinez, O Cords, Q Liu… - The Lancet Global …, 2022 - thelancet.com
Background BCG vaccines are given to more than 100 million children every year, but there
is considerable debate regarding the effectiveness of BCG vaccination in preventing …

Trained immunity-related vaccines: innate immune memory and heterologous protection against infections

A Ziogas, MG Netea - Trends in molecular medicine, 2022 - cell.com
The innate immune system is able to build memory-like features in response to certain
infections or vaccines, resulting in enhanced responsiveness upon (re) challenge with the …

[HTML][HTML] In situ immunomodulation of tumors with biosynthetic bacteria promote anti-tumor immunity

Z Lin, F Meng, Y Ma, C Zhang, Z Zhang, Z Yang, Y Li… - Bioactive Materials, 2024 - Elsevier
Immune checkpoint blockade (ICB) therapy potently revives T cell's response to cancer.
However, patients suffered with tumors that had inadequate infiltrated immune cells only …

Nanomaterials: small particles show huge possibilities for cancer immunotherapy

Z Chen, Z Yue, K Yang, S Li - Journal of Nanobiotechnology, 2022 - Springer
With the economy's globalization and the population's aging, cancer has become the
leading cause of death in most countries. While imposing a considerable burden on society …

Vaccine development against tuberculosis over the last 140 years: Failure as part of success

SHE Kaufmann - Frontiers in Microbiology, 2021 - frontiersin.org
The year 2020 was shaped by the COVID-19 pandemic which killed more people than any
other infectious disease in this particular year. At the same time, the development of highly …

Vaccine development against tuberculosis before and after Covid-19

SHE Kaufmann - Frontiers in Immunology, 2023 - frontiersin.org
Coronavirus disease (Covid-19) has not only shaped awareness of the impact of infectious
diseases on global health. It has also provided instructive lessons for better prevention …

VPM1002 as prophylaxis against severe respiratory tract infections including coronavirus disease 2019 in the elderly: a phase 3 randomized, double-blind, placebo …

AM Blossey, S Brückner, M May… - Clinical Infectious …, 2023 - academic.oup.com
Abstract Background Bacille Calmette-Guérin (BCG) vaccination can potentially reduce the
rate of respiratory infections in vulnerable populations. This study evaluates the safety and …

Immune memory in aging: a wide perspective covering microbiota, brain, metabolism, and epigenetics

O Bulut, G Kilic, J Domínguez-Andrés - Clinical reviews in allergy & …, 2022 - Springer
Non-specific innate and antigen-specific adaptive immunological memories are vital
evolutionary adaptations that confer long-lasting protection against a wide range of …

Advances in protein subunit vaccines against tuberculosis

Y Zhang, J Xu, Z Hu, X Fan - Frontiers in Immunology, 2023 - frontiersin.org
Tuberculosis (TB), also known as the “White Plague”, is caused by Mycobacterium
tuberculosis (Mtb). Before the COVID-19 epidemic, TB had the highest mortality rate of any …

Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice

S Afkhami, MR D'Agostino, M Vaseghi-Shanjani… - npj Vaccines, 2023 - nature.com
Viral-vectored vaccines are highly amenable for respiratory mucosal delivery as a means of
inducing much-needed mucosal immunity at the point of pathogen entry. Unfortunately …